Kleiton S. Borges

Av. Bandeirantes 3900
Ribeirao Preto, SP 14048900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

EGFR INHIBITION PROMOTES ENTEROENDOCRINE CELL DIFFERENTIATION CONTRIBUTING TO TREATMENT-ASSOCIATED DIARRHEA.

EGFR INHIBITION PROMOTES ENTEROENDOCRINE CELL DIFFERENTIATION CONTRIBUTING TO TREATMENT-ASSOCIATED DIARRHEA.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Establishment of Zone-Enriched Primary Cultures from the Mouse Adrenal Cortex.

Establishment of Zone-Enriched Primary Cultures from the Mouse Adrenal Cortex.

Journal: Journal of visualized experiments : JoVE

Published: May 25, 2026

Rho-ROCK signaling and α-Catenin mediate β-Catenin-driven hyperplasia in the adrenal via adherens junctions.

Rho-ROCK signaling and α-Catenin mediate β-Catenin-driven hyperplasia in the adrenal via adherens junctions.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

Journal: bioRxiv : the preprint server for biology

Published: November 19, 2025

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Journal: Scientific reports

Published: November 12, 2025

Rho/ROCK signaling and α-catenin mediate β-catenin-driven hyperplasia in the adrenal cortex via adherens junctions.

Rho/ROCK signaling and α-catenin mediate β-catenin-driven hyperplasia in the adrenal cortex via adherens junctions.

Journal: The Journal of clinical investigation

Published: June 02, 2025

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

Journal: Cancer communications (London, England)

Published: November 20, 2024

Non-canonical Wnt signaling triggered by WNT2B drives adrenal aldosterone production.

Non-canonical Wnt signaling triggered by WNT2B drives adrenal aldosterone production.

Journal: bioRxiv : the preprint server for biology

Published: September 04, 2024

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.

Journal: bioRxiv : the preprint server for biology

Published: September 04, 2024

Identifying prognostic hub genes and key pathways in pediatric adrenocortical tumors through RNA sequencing and Co-expression analysis.

Identifying prognostic hub genes and key pathways in pediatric adrenocortical tumors through RNA sequencing and Co-expression analysis.

Journal: Molecular and cellular endocrinology

Published: July 24, 2024

Abrogation of FGFR signaling blocks β-catenin-induced adrenocortical hyperplasia and aldosterone production.

Abrogation of FGFR signaling blocks β-catenin-induced adrenocortical hyperplasia and aldosterone production.

Journal: JCI insight

Published: July 17, 2024

Insights from a methylome-wide association study of antidepressant exposure.

Insights from a methylome-wide association study of antidepressant exposure.

Journal: Nature communications

Published: May 21, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026